Print This Post
Developing a new treatment for Motor Neurone Disease (MND) is a lengthy, demanding, and costly endeavor. Despite early promising results in laboratory tests, many potential treatments do not prove effective in human trials. This is a common point of failure in the development of new treatments.
A Solution
Translational research serves as a crucial link between lab-based studies and clinical trials. Its goal is to maximize the chances of new treatments successfully navigating the drug development process, advancing through clinical trials, and reaching those affected by MND.
How the MND Association Supports Translational Research
‘Countdown to a Cure’ provides a snapshot of the cutting-edge research funded by the MND Association, highlighting increased collaboration within the MND research community and innovative approaches to conducting clinical trials.
Technological advancements, significant research breakthroughs, and new partnerships are propelling our understanding of MND’s causes towards the development of potential treatments.
Acknowledgements
“We extend our deepest gratitude to all the donors, funders, and partners who support our research. Together, we share a unified goal to comprehend, treat, and ultimately conquer MND.”
— Dr. Sophie Nyberg, Programmes and Partnerships Manager
Learn More Below…
Whether you are directly affected by MND, interested in our research, a researcher, or a potential partner, we aim to clearly communicate the impact of your support on our translational research efforts.
For a concise summary, consider our ‘Quick Read Edition’. For a more comprehensive understanding, please explore our ‘Extended Edition’.
Dr Sam Moxon